A pilot randomised-controlled trial (RCT) of mindfulness-based cognitive therapy (MBCT) for youth with Inflammatory Bowel Disease (IBD) and Depression

niversity of Queensland0 个研究点目标入组 64 人开始时间: 2017年6月15日最近更新: 2020年3月10日

适应症

试验速览

暂无简介。

•Young adult (aged 16-29);
•Able to verbally communicate and write in English
•Able to give informed consent (for youth aged 16-18 both the participant and their parent/guardian will provide consent)
•Confirmed diagnosis of IBD
•Confirmed clinical diagnosis of depression and DASS depression subscale scores of 10 and above
•Attending the IBD outpatient clinic at the Mater Young Adult Health Centre Brisbane;
•Have access to internet-enabled computer
•Able to do light exercise because this program involves a mindful movement component
•Able to commit to attend the eight weekly sessions of two hours’ duration
•Able to commit to do home practice of up to 45 minutes per day over the 8 weeks of the study as this is a requirement of the program
•No change in antidepressant medication (dose or type) within three months of trial onset

•Individuals not meeting inclusion criteria will be excluded from the study
•Individuals who do not have conversational or written English;
•Individuals who may have limited or no capacity to self-care; and
•Individuals who have no depression or have extremely severe levels of depression or anxiety
•Individuals with major mental illness other than depression as its treatment as well as symptoms could interfere with their ability to participate in program (e.g. current psychotic symptoms, current PTSD, OCD etc.)
•Individuals with a history of alcohol or drug dependency
•Individuals with current alcohol or drug dependency as substance dependence that would impact on program participation
•Individuals scheduled for major surgery in the next 3 months as this would impact on their ability to attend the program for its entire duration
•Individuals who have been started on antidepressants or changed their antidepressant dose within three months of the study onset
•Individuals enrolled or participating in another psychological therapy study or pharmacological study within the last six months or intending to participate during this study duration
•Exacerbation of IBD symptoms (flare) as this will make it difficult for participants to attend weekly sessions and complete home practice

发起方

niversity of Queensland